Skip to main content

ZAMPHIA Survey Prepares to Relaunch in Zambia

May 27, 2021

The Zambia Population-Based HIV Impact Assessment (ZAMPHIA) is preparing to recommence fieldwork at the beginning of May, and staff and communities are being mobilized in anticipation of the relaunch. ZAMPHIA is measuring HIV incidence and prevalence and viral load suppression by taking a nationally representative sample of adults aged 15 years and older. The survey will help stakeholders assess the effectiveness of past and current HIV prevention and treatment programs, and support the government in guiding future actions. Survey results will also serve as a valuable HIV data resource for global health researchers, policymakers, and program planners.  

The survey was originally scheduled to take place in 2020 but was paused due to the COVID-19 pandemic. Now that COVID-19 in Zambia has improved, the Government of Zambia, in partnership with Ciheb and others, is moving forward with the relaunch of this PEPFAR-funded assessment and have put in place all necessary safety measures to protect staff and participants.

Contact

Center for International Health, Education, and Biosecurity
Institute of Human Virology

Anthony Okoth
Regional Communications Specialist

Related stories

    Wednesday, July 17, 2024

    The ZENITH Initiative -  Empowering Zambia  

    The Zambia Education Network for Implementation Science Training in Health (ZENITH), a research training collaboration between the University Teaching Hospital (UTH) in Lusaka and the University of Maryland Baltimore (UMB), is an educational program designed to provide short-, medium-, and long-term implementation science capacity in Zambia. The aim of ZENITH is to prepare Zambian professionals with research skills and knowledge to develop HIV service delivery innovations for key and vulnerable populations to help Zambia achieve sustained HIV epidemic control.    


    Friday, April 12, 2024

    PreVAIL Presented at CROI 2024 Conference

    The Prison PrEP Values, Adherence, and Implementation (PreVAIL) study was developed to address these knowledge gaps surrounding HIV prevention among justice-involved populations. Representing a collaborative effort between UMB, CIDRZ, and Zambia Correctional Services, PreVAIL is one of the first studies observational studies on PrEP uptake, persistence, and adherence among incarcerated persons.


    Wednesday, January 24, 2024

    Empowering Zambian Health Professionals through the ZENITH Implementation Science Institute

    The Zambia Education Network for Implementation Science Training in Health (ZENITH) marked a significant milestone with the successful launch of the Implementation Science Institute (ISI) in Lusaka.


    Tuesday, September 20, 2022

    National HIV Testing, Counselling, and Treatment Day in Zambia

    Zambia remains one of the countries that the HIV and AIDS epidemic hard hit. These factors necessitate spreading awareness of the importance of testing and treatment among Zambians.


    Tuesday, May 03, 2022

    Combating Gender-based Violence in Zambia

    Across three districts, 110 mentors were trained through CIHEB-Zambia’s partnership with the Determined, Resilient, Empowered, AIDS-free, Mentored and Safe (DREAMS).


    Wednesday, December 01, 2021

    Preliminary results of national HIV survey (BAIS V) demonstrate Botswana’s remarkable progress achieving HIV epidemic control

    Preliminary results from the fifth Botswana HIV/AIDS Impact Survey (BAIS V), announced today by the President, His Excellency Dr. Mokgweetsi E. K. Masisi demonstrate that for the first time at a national level among adults aged 15-64, Botswana has exceeded the 2020 UNAIDS 90-90-90 targets which call for 90 percent of all people living with HIV (PLHIV) to be aware of their status, 90 percent of those aware of their status to be on antiretroviral treatment (ART), and 90 percent of those on ART to achieve viral load suppression.


    Friday, November 19, 2021

    Ciheb Helps Author First Antibiotics Guidelines for a Zambian Hospital

    Ciheb and the University of Maryland, Baltimore, in conjunction with University Teaching Hospital in Lusaka, Zambia, have created the UTH antibiotics guidelines, the first of its kind for a health facility in Zambia.


    Saturday, September 25, 2021

    COVID-19 Team Helps Steer BAIS V Survey Through Field Implementation in Botswana

    At the resumption of the fifth Botswana HIV/AIDS Impact Survey (BAIS V), the project convened a small group of three to lead the COVID-19 response. Over the following months, this trio would lead a herculean effort to safeguard the health of staff and participants and allow the survey to proceed as safely as possible.


    Tuesday, September 07, 2021

    COVID-19 Symptoms Monitoring App Supports PHIA Surveys

    Working in partnership with national ministries of health, Ciheb has helped conduct population-based HIV impact assessments (PHIAs) in countries supported by PEPFAR. These surveys provide critical information about the status of HIV/AIDS by estimating HIV prevalence, or the total number of people living with HIV (PLHIV) in a country.


    Monday, August 30, 2021

    ZAMPHIA Prepares to Restart After Election Pause

    After a one month pause, the Zambia Population-based HIV Impact Assessment (ZAMPHIA) is prepared to restart field data collection in September. The survey now enters its final stage of field work following a break in August for the 2021 Zambian general elections.


    Tuesday, June 08, 2021

    ZAMPHIA Survey Begins Fieldwork

    The Zambia Population-Based HIV Impact Assessment (ZAMPHIA) is now underway! The survey was originally scheduled to take place in 2020 but was paused due to the COVID-19 pandemic. Now that COVID-19 in Zambia has improved, the Government of Zambia, in partnership with Ciheb and others, is moving forward with the relaunch of this PEPFAR-funded assessment and have put in place all necessary safety measures to protect staff and participants. ZAMPHIA is the second ever population-based HIV impact assessment performed in Zambia.